Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-02-28 Inbar Galia See "Remarks" Option exercise · Restricted Share Units −4,828 9,657
2022-02-28 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +21,682 73,098.51
2022-02-28 Fridriksdottir Hafrun Executive VP, Global R&D Sale −7,590 $8.14 $62K 65,508.51
2022-02-28 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −21,682 43,366
2022-02-28 Drape Eric Executive VP Global Operations Option exercise +19,514 55,627
2022-02-28 Drape Eric Executive VP Global Operations Sale −9,797 $8.14 $80K 45,830
2022-02-28 Drape Eric Executive VP Global Operations Option exercise · Restricted Share Units −19,514 39,029
2022-02-28 Dethlefs Sven EVP, North America Commercial Option exercise +17,346 104,319
2022-02-28 Dethlefs Sven EVP, North America Commercial Sale −4,862 $8.14 $40K 99,457
2022-02-28 Dethlefs Sven EVP, North America Commercial Option exercise · Restricted Share Units −17,346 34,692
2022-02-28 Daniell Richard Exec. VP, European Commercial Option exercise +20,598 40,878
2022-02-28 Daniell Richard Exec. VP, European Commercial Sale −20,598 $8.14 $168K 20,280
2022-02-28 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −20,598 41,197
2022-02-13 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option exercise +6,629 25,059
2022-02-13 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option exercise · Restricted Share Units −6,629 13,259
2022-02-09 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +12,538 15,512.39
2022-02-09 Stark David Matthew Exec. VP Chief Legal Officer Sale −6,110 $9.06 $55K 9,402.39
2022-02-09 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −12,538 0
2022-02-09 Schultz Kare President and CEO Option exercise +26,867 1,067,449
2022-02-09 Schultz Kare President and CEO Option exercise · Restricted Share Units −26,867 0

Page 41 of 76 · 1,517 trades